Brief: Altimmune Announces CEO Transition, Succession Plan
01/12/2025 12:38
Dec 1 (Reuters) - Altimmune Inc ALT.O: ALTIMMUNE ANNOUNCES CEO TRANSITION AND SUCCESSION PLAN ALTIMMUNE INC - JERRY DURSO TO SUCCEED VIPIN GARG AS CEO ALTIMMUNE INC - VIPIN GARG TO STEP DOWN AS CEO EFFECTIVE JAN 1, 2026 ALTIMMUNE INC - JERRY DURSO TO ASSUME ROLE OF CEO AND RETAIN CHAIRMAN POSITION ALTIMMUNE INC - VIPIN GARG TO SERVE AS ADVISOR THROUGH JUNE 30, 2026 Source text: ID:nGNX3zs7fc Further company coverage: ALT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Altimmune
See all newsFactbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Boehringer-Zealand's obesity drug shows promise in cutting visceral, liver fat
U.S. RESEARCH ROUNDUP-Costco Wholesale, HCA Healthcare, Micron Technology
Boehringer-Zealand drug leads to 16.6% weight loss in late-stage trial (updated)